Citi analysts upgraded CME Group (NASDAQ:CME) to 'Buy' from 'Hold', setting a US$300 price target and implying an 18% total return, citing an attractive risk/reward profile. The upgrade is predicated on numerous upcoming catalysts, including UST clearing and OSSTRA, a robust capital return outlook with an estimated $3.3 billion to $3.6 billion in shareholder returns, and the platform's defensive characteristics, despite recent headwinds from lower trading volumes.
Citi analysts have upgraded CME Group (CME) to 'Buy' from 'Hold', setting a US$300 price target that implies an 18% total return. The basis for the upgrade is a positive risk/reward profile at current levels, supported by several anticipated catalysts in the coming months, including UST clearing, OSSTRA, and a Fanduel partnership. The analysts' note highlights a robust capital return outlook, with an estimated $3.3 billion to $3.6 billion to be returned to shareholders through buybacks and dividends, funded by cash on hand, future generation, and OSSTRA proceeds. While acknowledging near-term headwinds from lower trading volumes due to reduced interest rate and energy volatility, Citi's research frames this as a strategic opportunity, noting that historically, stock weakness on low volumes has presented favorable entry points for acquiring CME shares.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment